• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于疾病干预的蛋白质清除策略。

Protein clearance strategies for disease intervention.

机构信息

Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph Stelzmann Strasse 26, 50931, Cologne, Germany.

Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.

出版信息

J Neural Transm (Vienna). 2022 Feb;129(2):141-172. doi: 10.1007/s00702-021-02431-y. Epub 2021 Oct 23.

DOI:10.1007/s00702-021-02431-y
PMID:34689261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8541819/
Abstract

Protein homeostasis, or proteostasis, is essential for cell function and viability. Unwanted, damaged, misfolded and aggregated proteins are degraded by the ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway. Growing evidence indicates that alterations in these major proteolytic mechanisms lead to a demise in proteostasis, contributing to the onset and development of distinct diseases. Indeed, dysregulation of the UPS or autophagy is linked to several neurodegenerative, infectious and inflammatory disorders as well as cancer. Thus, modulation of protein clearance pathways is a promising approach for therapeutics. In this review, we discuss recent findings and open questions on how targeting proteolytic mechanisms could be applied for disease intervention.

摘要

蛋白质动态平衡,或蛋白质稳态,对细胞功能和活力至关重要。细胞通过泛素-蛋白酶体系统(UPS)和自噬-溶酶体途径降解不需要的、受损的、错误折叠和聚集的蛋白质。越来越多的证据表明,这些主要的蛋白水解机制的改变导致蛋白质动态平衡的丧失,导致不同疾病的发生和发展。事实上,UPS 或自噬的失调与几种神经退行性、感染性和炎症性疾病以及癌症有关。因此,调节蛋白清除途径是一种有前途的治疗方法。在这篇综述中,我们讨论了靶向蛋白水解机制在疾病干预中的应用的最新发现和未解决的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/2b956b056031/702_2021_2431_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/1230b947fb0d/702_2021_2431_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/e255b883248e/702_2021_2431_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/2b956b056031/702_2021_2431_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/1230b947fb0d/702_2021_2431_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/e255b883248e/702_2021_2431_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/8866288/2b956b056031/702_2021_2431_Fig3_HTML.jpg

相似文献

1
Protein clearance strategies for disease intervention.用于疾病干预的蛋白质清除策略。
J Neural Transm (Vienna). 2022 Feb;129(2):141-172. doi: 10.1007/s00702-021-02431-y. Epub 2021 Oct 23.
2
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.神经退行性疾病中错误折叠蛋白的降解:治疗靶点与策略
Exp Mol Med. 2015 Mar 13;47(3):e147. doi: 10.1038/emm.2014.117.
3
Removing protein aggregates: the role of proteolysis in neurodegeneration.去除蛋白质聚集体:蛋白水解在神经退行性变中的作用。
Curr Med Chem. 2011;18(16):2459-76. doi: 10.2174/092986711795843236.
4
Proteostasis in neurodegenerative diseases.神经退行性疾病中的蛋白稳态。
Adv Clin Chem. 2024;121:270-333. doi: 10.1016/bs.acc.2024.04.002. Epub 2024 Apr 30.
5
The role of protein clearance mechanisms in organismal ageing and age-related diseases.蛋白质清除机制在机体衰老和与年龄相关疾病中的作用。
Nat Commun. 2014 Dec 8;5:5659. doi: 10.1038/ncomms6659.
6
Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.泛素蛋白酶体系统的故障:神经退行性疾病的风险。
Neurodegener Dis. 2014;14(4):161-75. doi: 10.1159/000367694. Epub 2014 Nov 20.
7
Heat Shock Proteins and Autophagy Pathways in Neuroprotection: from Molecular Bases to Pharmacological Interventions.热休克蛋白与自噬通路在神经保护中的作用:从分子基础到药物干预。
Int J Mol Sci. 2018 Jan 22;19(1):325. doi: 10.3390/ijms19010325.
8
The ubiquitin-proteasome system in neurodegeneration.泛素-蛋白酶体系统在神经退行性疾病中的作用。
Antioxid Redox Signal. 2014 Dec 10;21(17):2302-21. doi: 10.1089/ars.2013.5802. Epub 2014 Feb 27.
9
Protein damage, repair and proteolysis.蛋白质损伤、修复与蛋白质降解。
Mol Aspects Med. 2014 Feb;35:1-71. doi: 10.1016/j.mam.2012.09.001. Epub 2012 Oct 26.
10
Contribution of proteases to the hallmarks of aging and to age-related neurodegeneration.蛋白酶对衰老特征和与年龄相关的神经退行性变的贡献。
Aging Cell. 2022 May;21(5):e13603. doi: 10.1111/acel.13603. Epub 2022 Mar 29.

引用本文的文献

1
A Unified Pathogenesis of Allergic Diseases; The Protein-Homeostasis-System Hypothesis.过敏性疾病的统一发病机制;蛋白质稳态系统假说
Int J Mol Sci. 2025 Aug 28;26(17):8358. doi: 10.3390/ijms26178358.
2
The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation.衰老因子EPS8通过RAC信号过度激活诱导疾病相关蛋白聚集。
Nat Aging. 2025 Sep 3. doi: 10.1038/s43587-025-00943-w.
3
Effect of recombinant protein production and release on microalgal fitness and the impact of environmental conditions for localized therapeutic delivery.

本文引用的文献

1
Rewiring of the ubiquitinated proteome determines ageing in C. elegans.泛素化蛋白质组的重排决定了线虫的衰老。
Nature. 2021 Aug;596(7871):285-290. doi: 10.1038/s41586-021-03781-z. Epub 2021 Jul 28.
2
Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.淀粉样蛋白聚集的机制及其被抗体、小分子抑制剂、纳米颗粒和纳米抗体抑制的情况。
Int J Biol Macromol. 2021 Sep 1;186:580-590. doi: 10.1016/j.ijbiomac.2021.07.056. Epub 2021 Jul 14.
3
Approval of Aducanumab for Alzheimer Disease-The FDA's Perspective.
重组蛋白的产生和释放对微藻适应性的影响以及环境条件对局部治疗性递送的影响。
J Biol Eng. 2025 Jun 4;19(1):54. doi: 10.1186/s13036-025-00525-9.
4
Mapping the interaction surface between Caβ and actin and its role in calcium channel clearance.绘制Caβ与肌动蛋白之间的相互作用表面及其在钙通道清除中的作用。
Nat Commun. 2025 May 10;16(1):4352. doi: 10.1038/s41467-025-59548-x.
5
Proteostasis and Its Role in Disease Development.蛋白质稳态及其在疾病发展中的作用。
Cell Biochem Biophys. 2025 Jun;83(2):1725-1741. doi: 10.1007/s12013-024-01581-6. Epub 2024 Oct 18.
6
Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity.橄榄苦苷增强蛋白酶体活性并降低突变型亨廷顿蛋白诱导的细胞毒性。
Front Pharmacol. 2024 Sep 13;15:1459909. doi: 10.3389/fphar.2024.1459909. eCollection 2024.
7
An antireductant approach ameliorates misfolded proinsulin-induced hyperglycemia and glucose intolerance in male Akita mice.一种抗还原方法可改善雄性秋田小鼠中错误折叠的胰岛素原诱导的高血糖和葡萄糖不耐受。
Geroscience. 2025 Apr;47(2):1653-1668. doi: 10.1007/s11357-024-01326-6. Epub 2024 Sep 19.
8
Novel strategies in Parkinson's disease treatment: a review.帕金森病治疗的新策略:综述
Front Mol Neurosci. 2024 Aug 9;17:1431079. doi: 10.3389/fnmol.2024.1431079. eCollection 2024.
9
Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review.探索抗糖尿病药物作为阿尔茨海默病和帕金森病治疗方法的潜力:一项综述。
Cureus. 2023 Sep 6;15(9):e44763. doi: 10.7759/cureus.44763. eCollection 2023 Sep.
10
Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases.NFE2L1在蛋白质稳态调节中的作用:对衰老和神经退行性疾病的影响
Biology (Basel). 2023 Aug 25;12(9):1169. doi: 10.3390/biology12091169.
阿杜卡努单抗获批用于治疗阿尔茨海默病——美国食品药品监督管理局的观点。
JAMA Intern Med. 2021 Oct 1;181(10):1276-1278. doi: 10.1001/jamainternmed.2021.4607.
4
Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases.神经退行性疾病中的化学介导靶向蛋白质降解
Life (Basel). 2021 Jun 24;11(7):607. doi: 10.3390/life11070607.
5
Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?重新思考神经退行性疾病中的蛋白质聚集和药物发现:为什么我们需要接受复杂性?
Curr Opin Chem Biol. 2021 Oct;64:67-75. doi: 10.1016/j.cbpa.2021.05.006. Epub 2021 Jun 23.
6
Brain Targeting and Aβ Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP/PS1 Transgenic Mice.脑靶向和 Aβ 结合双功能纳米颗粒抑制 APP/PS1 转基因小鼠的淀粉样蛋白聚集。
ACS Chem Neurosci. 2021 Jun 16;12(12):2110-2121. doi: 10.1021/acschemneuro.1c00035. Epub 2021 May 27.
7
The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白ORF3a抑制自噬体与溶酶体的融合。
Cell Discov. 2021 May 4;7(1):31. doi: 10.1038/s41421-021-00268-z.
8
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease.抑制 GSK-3 可改善亨廷顿病的发病机制。
Neurobiol Dis. 2021 Jul;154:105336. doi: 10.1016/j.nbd.2021.105336. Epub 2021 Mar 19.
9
GSK3B induces autophagy by phosphorylating ULK1.糖原合成酶激酶3β(GSK3B)通过磷酸化Unc-51样自噬激活激酶1(ULK1)诱导自噬。
Exp Mol Med. 2021 Mar;53(3):369-383. doi: 10.1038/s12276-021-00570-6. Epub 2021 Mar 2.
10
Generation and identification of a conditional knockout allele for the PSMD11 gene in mice.在小鼠中生成和鉴定 PSMD11 基因的条件性敲除等位基因。
BMC Dev Biol. 2021 Feb 1;21(1):4. doi: 10.1186/s12861-020-00233-1.